๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858

โœ Scribed by Jan Sejbal; Yunjun Wang; John R. Cann; John M. Stewart; Lajos Gera; George Kotovych


Publisher
Wiley (John Wiley & Sons)
Year
1997
Tongue
English
Weight
228 KB
Volume
42
Category
Article
ISSN
0006-3525

No coin nor oath required. For personal study only.

โœฆ Synopsis


Extensive proton magnetic resonance experiments were carried out on three bradykinin peptide antagonists B-9430, B-9436, and B-9858 in aqueous solutions as well as in sodium dodecylsulphate micelles (B-9430 and B-9436) and CD 3 OH/H 2 O (60%/40%) mixtures for B-9858. All three peptides showed no observable secondary structure in aqueous solution. However, in their respective structure-inducing solvents, B-9430 (B 1 and B 2 receptor antagonist) and B-9436 (a B 2 receptor antagonist) exhibit a type II b-turn involving residues 2-5, and B-9430 also exhibits a type II b-turn involving residues 6-9 (in sodium dodecylsulfate micellar solutions), whereas B-9858, a B 1 -specific receptor antagonist, exhibits only a type II b-turn involving residues 2-5 (in CD 3 OH/H 2 O solutions). Simulated annealing calculations on B-9858 confirm the experimental conclusions based on the nmr data. In addition, simulated annealing of the (2S, 3aS, 7aS)-octahydroindole-2-carboxylic acid (Oic residue), which is present in two of the three decapeptides studied, show that the one-chair conformation of the six-membered ring predominates, in agreement with the experimental data. The activities of these peptides are compared with their secondary structures and the specific receptor activity appears to depend on the presence of specific amino acid residues, such as N-(2-indanyl)glycine (Nig) and D[ a-(2-indanyl)glycine] (D-Igl) as well as on elements of secondary structure.


๐Ÿ“œ SIMILAR VOLUMES


Differential expression of adenosine A2A
โœ Robin Munro; Rose Ressner; Maureen Stone; George Gessner; Michael F. Jarvis; Ala ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 155 KB ๐Ÿ‘ 2 views

The ability of adenosine to function as an inhibitory modulator of inflammatory processes has been well documented. While the activation of adenosine A 2 receptors has been implicated in the anti-inflammatory actions of adenosine, the specific mechanisms by which adenosine modulates the function of